Home > Publications database > Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study. > print |
001 | 148755 | ||
005 | 20240229133153.0 | ||
024 | 7 | _ | |a 10.1016/j.exger.2019.110815 |2 doi |
024 | 7 | _ | |a pmid:31857132 |2 pmid |
024 | 7 | _ | |a 0531-5565 |2 ISSN |
024 | 7 | _ | |a 1873-6815 |2 ISSN |
024 | 7 | _ | |a altmetric:73100578 |2 altmetric |
037 | _ | _ | |a DKFZ-2019-03268 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Ebert, Helen |b 0 |
245 | _ | _ | |a Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study. |
260 | _ | _ | |a Amsterdam [u.a.] |c 2020 |b Elsevier Science |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1611213077_29169 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a Volume 131, March 2020, 110815 |
520 | _ | _ | |a Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study. |
536 | _ | _ | |a 323 - Metabolic Dysfunction as Risk Factor (POF3-323) |0 G:(DE-HGF)POF3-323 |c POF3-323 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Lacruz, Maria Elena |b 1 |
700 | 1 | _ | |a Kluttig, Alexander |b 2 |
700 | 1 | _ | |a Simm, Andreas |b 3 |
700 | 1 | _ | |a Greiser, Karin Halina |0 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b |b 4 |u dkfz |
700 | 1 | _ | |a Tiller, Daniel |b 5 |
700 | 1 | _ | |a Kartschmit, Nadja |b 6 |
700 | 1 | _ | |a Mikolajczyk, Rafael |b 7 |
773 | _ | _ | |a 10.1016/j.exger.2019.110815 |g p. 110815 - |0 PERI:(DE-600)2005397-6 |p 110815 |t Experimental gerontology |v 131 |y 2020 |x 0531-5565 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:148755 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Herz-Kreislauf-Stoffwechselerkrankungen |1 G:(DE-HGF)POF3-320 |0 G:(DE-HGF)POF3-323 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Metabolic Dysfunction as Risk Factor |x 0 |
914 | 1 | _ | |y 2020 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EXP GERONTOL : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C020-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|